HNN3.0

CLUSTER Health Horizon Europe Brokerage Event 2026

26–30 Jan 2026

HomeParticipantsMarketplaceAgenda

Queen's University Belfast

University

www.qub.ac.uk/Belfast, United Kingdom
1 profile visit

About

A prestigious Russell Group UK university, Queen's University Belfast is ranked in the top 200 universities in the world (QS World University Rankings 2026)

Representatives

Clinical Professor Paediatric Cardiology

Queen's University Belfast

Professor of Vascular and Regenerative Medicine

Queen's University Belfast

Director Future Medicines Institute

Queen's University Belfast

Marketplace (3)

  • Project cooperation

    Generating 3D human models

    Professor Margariti leads one of the most advanced iPSCs centres in UK. Cells generated and differentiated into a wide array of cell types.

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Professor of Vascular and Regenerative Medicine at Queen's University Belfast

    BELFAST, United Kingdom

  • Project cooperation

    Regulatory Science Partner

    Regulatory Science Professional with 25+ years experience across industry, academia, public sector based in the Future Medicines Institute.

    • Partner seeks Consortium/Coordinator
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Director Future Medicines Institute at Queen's University Belfast

    BELFAST, United Kingdom

  • Project cooperation

    Professor Frank Casey OBE

    Clinical Professor Paediatric Cardiology, Queen's University Belfast and Ulster University

    Clinical Professor Paediatric Cardiology at Queen's University Belfast

    Belfast, United Kingdom